Michaelirish, I was a bit worried about the headlines myself. However if you follow up the original publication, it will show that Quantiferon is not one of the tests it has reviewed. All the tests are for active TB - pulmonary TB, for which QFF is not aimed at, at present, but probably works very well for as well. CHeck out :
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0040202
Cheers
- Forums
- ASX - By Stock
- report
Michaelirish, I was a bit worried about the headlines myself....
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.90M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1275 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.3¢ | 326144 | 2 |
Last trade - 07.04am 02/12/2024 (20 minute delay) ? |
Featured News
CST (ASX) Chart |
Day chart unavailable
The Watchlist
NXD
NEXTED GROUP LIMITED
Nick Poll, Managing Director
Nick Poll
Managing Director
SPONSORED BY The Market Online